2012 Scrip 100 Preview: Pipeline dreams - an interview with Joe Jimenez
This article was originally published in Scrip
As we sit in Novartis’s Basel headquarters on a sunny October afternoon, discussing the pharmaceutical company’s growth strategy in the coming years, Joe Jimenez conducts himself as you would imagine the CEO of a major pharma company to appear: prepared, confident and direct.
You may also be interested in...
Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.
"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"